Harris Cohen, MD
Family Medicine · Horsham, PANPI 1801887856
Payments from drug & device makers
Across 1,046 payments — averaging $3562.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$2.8M
- Merck$406K
- Novartis$247K
- AstraZeneca$181K
- Genentech, Inc.$61K
- Sanofi US Services Inc.$38K
- plus $37K from 32 others
Across 1 payment — averaging $1089.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 726 | $2,757,411 |
| Merck | 14 | $405,769 |
| Novartis | 10 | $247,149 |
| AstraZeneca | 45 | $181,288 |
| Genentech, Inc. | 31 | $60,609 |
| Sanofi US Services Inc. | 15 | $37,879 |
| Adaptive Biotechnologies Corporation | 5 | $27,790 |
| Pfizer | 38 | $3,827 |
| Sekisui Diagnostics LLC | 4 | $1,040 |
| Currax Pharmaceuticals LLC | 1 | $750 |
| Novo Nordisk | 34 | $565 |
| GSK | 19 | $337 |
| AbbVie(2 entities) | 17 | $327 |
| Amgen | 10 | $298 |
| Teva Pharmaceuticals USA, Inc. | 5 | $238 |
| BD | 1 | $171 |
| Bayer | 8 | $166 |
| Lilly USA, LLC | 11 | $156 |
| Boehringer Ingelheim | 7 | $136 |
| Sanofi-aventis U.S. LLC | 7 | $131 |
| Abbott | 6 | $116 |
| Amarin Pharma, Inc. | 5 | $86 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| GE HealthCare | 1 | $60 |
| Exact Sciences | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Johnson & Johnson | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Vertos Medical, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Intuity Medical Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Kaleo, Inc. | 1 | $12 |
How this compares
$3,726,756 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Horsham
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
- Nathan BennettPittsburgh$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.